chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Few minutes after vaccine indicated chest pain that passed/ she had chest pains on/off from day she received first dose; This is a spontaneous report from a contactable consumer, the patient.   A 13-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW0181), dose 1 via an unspecified route of administration, administered in arm left on 07Jul2021 at 17:30 (age at vaccination 13-years-old)  as DOSE 1, SINGLE for covid-19 immunization. Facility where the most recent COVID-19 vaccine was administered was Pharmacy or Drug Store. Medical history included chest pains (chest pains documented when younger) and POTS (Postural orthostatic tachycardia syndrome) from an unknown date and unknown if ongoing. Patient had known allergies to scallops. There were no concomitant medications (List of any other medications the patient received within 2 weeks of vaccination: No). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported patient received first dose of Covid Vaccine on 07Jul2021, few minutes after vaccine indicated chest pain that passed, assumed preliminary reaction based on expected side effects.  Patient did not complain after that.  She went to beach with friend. Today 28Jul2021 she was scheduled to get second vaccine but she informed that she had continued chest pains when she was at the beach 2 weeks prior and that she had chest pains on/off from day she received first dose until day after returned from beach (17Jul2021).  She indicated she had not had them since. Due to this second dose was proceeded to be cancelled which was scheduled for today and possibly consider waiting a little to get second dose. Also it was asked if the second dose could get delayed. The event did not result in hospitalization. Patient did not receive any treatment for the event. The event was reported as non-serious. The clinical outcome of the event was recovered on 17Jul2021.  Information on the lot/ batch number is available. Additional information has been requested.
This spontaneous report was received from a physician via company representatives and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions or concomitant therapies were not reported. On 11-SEP-2014, the patient was vaccinated orally with a dose of 2 ml of ROTATEQ 10 unit dose tube, lot # K000487, expiration date 27-SEP-2015. This vaccine was improperly stored exposed to two temperature excursions, one for a sum of 168 hours with the lowest temperature recorded as 34 degrees F (1.111111111 degrees C); and other for a sum of 24 hours with a lowest temperature recorded as 33 degrees F (0.555555556 degrees C). The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator(R)". No adverse effects were reported. There was no product quality complain involved. This is one of several reports received from the same reporter. Additional information has been requested.
Had vaccines 12-14-11. 12-15-11 Developed redness, swelling and pain. Treatment of BENADRYL as needed. Ibuprofen as needed, ice and elevation of arm, moderate activity.
Injection site (arm) pain, headache, fatigue, full body chills, fever of 101.3, vomiting, diarrhea, lightheadedness, pale face, dizzy. Lasted about 3 days.  Tylenol was taken every 6 hours to help with fever and arm pain.
Pt was brought in 2 days after immun. 36 hours after injection mom noticed hot red spot on leg of DTaP. This was a 10 cm in diameter mottled area. Mom used cool compress in am. No fever, chills, trouble breathing or vomiting. No treatment needed.
pt recv vax 29JAN96 & that same day pt exp extreme fatigue, h/a that don't resolve, dizziness, aching all over, lethargy, nausea & intermittent abd pain;
This case was initially reported by a nurse on 16.Jul.2009. The female patient was vaccinated with oral VIVOTIF (Batch no.: UNKNOWN) on 16.Jul.2009 at 5:30 am. The patient developed ABDOMINAL PAINS, CRAMPING, DIARRHEA on the same day at 9:30 am. She contacted the nurse who referred her to the physician. Advised by physician, she took PEPTO BISMOL and felt better. Several hours later she contacted again the nurse with sharp pains in the left upper quadrant of abdomen. Advised again to contact physician, who ordered her to emergency room with suspicion of VIVOTIF adverse events or pancreatitis. Follow-up information requested on 17.Jul.2009.
This is a 30-year-old female with no significant past medical history who presents to RMC ED with complaints of acute onset headache and left-sided weakness shortly after receiving her first Pfizer COVID-19 vaccine today. Patient states that after the injection she immediately had a headache and several minutes later she developed left-sided numbness tingling and subsequent weakness. She was activated as a code stroke.  CT head, CTA head and neck were unremarkable.  Patient was evaluated neurology was thought that her symptoms are likely related to vaccine reaction as opposed to acute CVA she is not given TPA. Upon my assessment patient states that she continues to have left-sided weakness both her arm and her leg. She has decreased sensation on her left side.  She is able to move her left extremities however she states that they feel heavy and weak. Patient was given Benadryl IV as well as famotidine in the ED.  She will be given Solu-Medrol as well. Patient denies any history of any vaccine reactions in the past, to penicillin and seasonal allergies otherwise denies any sensitivities.  Denies any history of autoimmune diseases.   Patient denies any HA, dizziness, vision changes, chest pain, shortness of breath, abdominal pain, nausea, vomiting, diarrhea, fevers chills, dysuria.  This is a 30-year-old female with no significant past medical history who presents to RMC ED with complaints of acute onset headache and left-sided weakness shortly after receiving her first Pfizer COVID-19 vaccine 4/9/21.  Patient states that after the injection she immediately had a headache and several minutes later she developed left-sided numbness tingling and subsequent weakness. She was activated as a code stroke.    CT head, CTA head and neck were unremarkable.  Patient was evaluated neurology was thought that her symptoms are likely related to vaccine reaction as opposed to acute CVA she is not given TPA.  Admitting physician felt she has decreased sensation on her left side.  She is able to move her left extremities however she states that they feel heavy and weak. Patient was given Benadryl IV as well as famotidine in the ED.  She will be given Solu-Medrol as well.  Patient denies any history of any vaccine reactions in the past, to penicillin and seasonal allergies otherwise denies any sensitivities.    Denies any history of autoimmune diseases.   Pt has improved. She is able to move her LUE and LLE now. " Does not feel like moving bricks " Her tingling has decreased and she is able to feel things again with her left hand and leg.   Pt had c/o chest pain 4/11/21.  Her trop have  been neg. EKG neg. D-dimer within normal limits.   Will give dose of  mobic 7.5 mg.  Will try lidoderm patches for pain.  Pt will follow up with pcp in 1-2 weeks.
Swelling. Lot of pain. very red. some limited use of the arm where the pneumonia shot was given.
Myalgia, Rash, UrticariaPruritus, INJECTION SITE PAIN Narrative:
Developed alopecia on an eyebrow in June 2021, 2 months after both doses of the Pfizer COVID vaccine in spring 2021. After receiving a booster (Moderna) in November 2021, another alopecia spot appeared on the scalp 4 months later. After receiving the Pfizer Bivalent Booster in September 2022, another alopecia spot appeared on the scalp 2 months later.   No additional spots appeared during this time period?I have been receiving monthly cortisone shots to encourage growth from Dr. since December 2021, previously I saw different Dr. July 2021 (she made the initial diagnosis).
pt devel inject site rxn w/ redness, itching and a knot.  This is 1 of 4 patients from this site and lot# to report adverse reactions.
Tremors to fingers which started soon after injection.  Extreme pulsation to arms, from Elbows to hands.  Has not been treated but reactions continues even today 08/27/2022
Patient said she experienced numbness on right arm and left arm. She had it before only on right, but says it got worse 2 days after shot. Not sure if related to the shot
worst flu: Initial information was received on 04-Dec-2021 regarding an unsolicited valid Regulatory Authority non-serious case from a consumer/non-healthcare professional.  This case involves an unknown age and gender patient who experienced worst flu (influenza) after receiving INFLUENZA VACCINE.  The patient's medical treatments, vaccinations, concomitant medication and family history were not provided.  It was unknown if the patient had any medical history, concomitant disease or risk factor.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious worst flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It was unknown if the patient experienced any additional symptoms/events.  It was unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment for the event.  The outcome was unknown for the events.  There will be no information available on the batch number for this case.
Nausea/vomiting, stomach pains, headache, fever, chills, body aches
Cellulitis left upper arm. 2nd to VARIVAX shot given at health center
Became pale, hot and diaphoretic within 2 minutes. Entire body became red then faded. Developed hives in 2 hours. Got jittery and numbness in left arm. Itchy throughout the evening. Strange dreams for two nights. c/o tiredness, nausea, and diarrhea the next day. Is currently tired, but feeling better.
Patient says her arm is still sore today that she can barely raise her arm and that she can still see injection site spot.  She says she started icing it about 3 days after getting the shot.
strawberry tongue /taste buds popped up and inflamed like I'd eaten something sour.  It was all inflamed; rash the next day and a few days after I got a rash on my chest; This is a spontaneous report from a contactable healthcare professional, the patient.  A 38-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in Dec2020 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient did not have a history of rash or food allergies.  In Dec2020, the patient experienced strawberry tongue and rash. The clinical course was as follows: the patient stated that she believed she had a delayed reaction to the vaccine as it didn't happen within 15 minutes.  It happened later on (not further specified).  She started to get a strawberry tongue and described it as "taste buds popped up and inflamed like she had eaten something sour."  It was all inflamed.  She also noticed a rash the next day and a few days after she got a rash on her chest. The clinical outcomes of the strawberry tongue and rash were unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
six hours after the vaccine, very sleepy, light chills/body aches, had to take a nap from tiredness. Woke up 20 min later, chills and body symptoms continued to worsen. Got very bad, could not get off the couch, in lots of pain. Nausea started. Light headache, Lasted for about 6 hours until I decided to take Tylenol and a bath. This helped immensely! After the bath I got very warm, burning up. Slept some and the next day felt significantly better. Light body aches and headache, tired. Back to almost 100% two days later/48 hrs.
Patient fainted within 15 seconds after receiving the vaccine. Patient came too within 15 seconds after passing out. Patient was observed for approximately 30 minutes after fainting and felt well enough to go home without the pharmacy contacting the local EMS .Patient called the pharmacy when she arrived safely at home per the pharmacist's request.
Attendee received first dose Pfizer vaccine at 11:15 am in the Left arm.  Lot# EW0217. Attendee was directed to observation area.   At 11:20 voiced complaints of feeling unwell.  Attendee's skin was cold, clammy, and pale.  Attendee's respirations were not tachypneic or dyspneic. Denied dizziness.  Reported anxiety with injections in the past.  Continuous Pulse oximetry applied.  HR: 48    BP:  116/80   RR:   Unable to assess   O2Sat%:  100  11:22 - Attendee assisted to the cot to lie down. Had him take some deep breaths and he was given some cool water to sip on.      11:25 - Attendee stated he felt much better, no longer clammy or pale.   HR:  60   BP:  118/78   RR:   16   O2Sat%:  100  11:48 -Denied complaints and joking with staff.   HR:  58   BP:  Not taken   RR:   16   O2Sat%:  100   Temp:    11:50 - Care Practitioner educated on home discharge/adverse reaction instructions and attendee was discharged to home with his wife.     Attendee did not have any reported escalation of symptoms and was able to walk out of clinic independently.  Attendee was retained for a longer observation time to make sure that it was safe for them to leave.
This spontaneous report was received from a Registered Nurse (R.N) referring to a 60 year old male patient. The patient's concurrent conditions included obesity, hypertension and diabetes. He did not have known drug allergies. Concomitant medications were not reported. On 28-JUL-2016, the patient was vaccinated with ZOSTAVAX (19400 PFU: plaque-forming units), subcutaneous. Lot # and anatomical location were not reported. On 01-AUG-2016 (reported as "4 days later"), the patient experienced a red, itchy, blistering rash on his mid back and anterior chest, and he complained of burning pain. The reporter stated that the patient was seen in the office on 08-AUG-2016 and the physician prescribed Acyclovir and Ibuprofen. The reporter also stated that the patient would be seen on 22-AUG-2016. It was not product quality complaint involved. At the time of reporting the outcome of the events was unknown. The causality assessment between the events and the suspect therapy was not reported. Additional information has been requested.
Convulsing. Jerking of limbs. Gasping for breath. Coughing. Extreme discomfort. Inconsolable crying. Severe swelling rash and redness around injection site. Vomiting. Child was given Advil for pain doctor said not to take child to ER unless childs condition continues to increase in severity.
she took The Johnson and Johnson for the first  dose, the Moderna covid19 vaccine for the second dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (she took The Johnson and Johnson for the first  dose, the Moderna covid19 vaccine for the second dose) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039T20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Previously administered products included for Product used for unknown indication: Johnson and Johnson (The patient took  Johnson and Johnson as the first dose.). Past adverse reactions to the above products included No adverse event with Johnson and Johnson. Concomitant products included ALPRAZOLAM (XANAX) for an unknown indication.    On 06-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (she took The Johnson and Johnson for the first  dose, the Moderna covid19 vaccine for the second dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (she took The Johnson and Johnson for the first  dose, the Moderna covid19 vaccine for the second dose) outcome was unknown.            No treatment information was provided.   This case was linked to MOD-2022-537899 (Patient Link).
Received a dose from a vial first punctured more than 12 hours ago; The vial was opened yesterday (09Sep2021) and then was left in the refrigerator; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received a dose from a vial first punctured more than 12 hours ago) and PRODUCT STORAGE ERROR (The vial was opened yesterday (09Sep2021) and then was left in the refrigerator) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received a dose from a vial first punctured more than 12 hours ago) and PRODUCT STORAGE ERROR (The vial was opened yesterday (09Sep2021) and then was left in the refrigerator). On 10-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Received a dose from a vial first punctured more than 12 hours ago) and PRODUCT STORAGE ERROR (The vial was opened yesterday (09Sep2021) and then was left in the refrigerator) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medication were reported. No treatment medication were reported.
approx 10 mins p/vax pt exp HR inc, BP & difficulty breathing; pt was treated in hosp ER w/DPH, 02, & IV fluids;
Itching, swelling, warm to touch, pink in color. On Feb 4, the size of mosquito bite.   The next 24 hours which is day 11 it had a diameter of 4 inches.
Nausea; Vomiting; dull headache/ headache became worse; This case was reported by a consumer via call center representative and described the occurrence of headache aggravated in a 56-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (in November 2017), hysterectomy (in 2001) and migraine. Previously administered products included Valaciclovir with an associated reaction of headache (received in November 2017).   On 26th September 2019, the patient received the 1st dose of Shingrix (intramuscular). On 27th September 2019, 1 days after receiving Shingrix, the patient experienced headache aggravated. On 30th September 2019, the patient experienced nausea and vomiting. The patient was treated with excedrin unknown, paracetamol (Tylenol) and ibuprofen (Advil). On an unknown date, the outcome of the headache aggravated, nausea and vomiting were not recovered/not resolved.   It was unknown if the reporter considered the headache aggravated, nausea and vomiting to be related to Shingrix.  Additional case details were provided as follows: The patient reporter for herself. The patient did not know the manufacturer of Valacyclovir which she received in November 2017. She mentions that, she experienced headache after taking the Valacyclovir and had to go to the emergency room. She had MRI (Nuclear magnetic resonance imaging) and blood work done at the hospital. She was discharged the same day from hospital.  The patient received Shingrix in right arm The patient experienced dull headache on 27th, 28th and 29th Septemebr 2019.  On 30th September 2019, her headache became worse. The headache was worse on waking up.  On the same day, she also experienced nausea and vomiting. The headache, nausea and vomiting were on an on and off basis. The headache was still present till the date of reporting. She had tried taking Tylenol, Excedrin and Advil and nothing had helped her. The patient messaged her doctor about her experience and was waiting to hear back from the doctor. The patient consented to follow up.  No further details were provided.
COVID 19 Treatment; COVID 19 Treatment; Tested positive six days after testing negative, and 17 days after my first dose of Paxlovid; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 27Jan2021 as dose 1, single (Lot number: EL9262), in right arm, on 13Feb2021 as dose 2, single (Lot number: EL9264), in right arm and on 30Sep2021 as dose 3 (booster), single (Lot number: 778839) at the age of 51 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "Depression" (unspecified if ongoing); "Seasonal Allergies" (unspecified if ongoing); "Dry Eye" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID, start date: 01Jan2021; SERTRALINE, start date: 01Jan2022; ZYRTEC [CETIRIZINE HYDROCHLORIDE], start date: 01Jan2022. he following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "recovering" and all described as "COVID 19 Treatment"; DISEASE RECURRENCE (medically significant) with onset 2022, outcome "recovering", described as "Tested positive six days after testing negative, and 17 days after my first dose of Paxlovid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Tested positive six days after testing negative; (unspecified date) Negative, notes: Tested positive six days after testing negative; (26Jul2022) Positive, notes: Tested positive six days after testing negative, and 17 days after my first dose of Paxlovid. Therapeutic measures were taken as a result of drug ineffective, covid-19, disease recurrence. Clinical Course: The patient received anti viral treatment with Paxlovid from 09Jul2022 to 14Jul2022 for treatment of COVID-19. The patient had tested positive six days after testing negative, and 17 days after my first dose of Paxlovid.  No follow-up attempts are possible. No further information is expected.
Patient received incorrect Covid-19 vaccine. Patient should have received the Pfizer Bivalent vaccine. Instead that patient received the Pfizer Monovalent vaccine.
The adverse event has nothing to do with the vaccination of Sept 7. The event was on Feb 21st that has to do with my seasonal allergies or flu. I took the COVID-19 test and it was negative. I felt tired and fatigue, congestion that give me headache. I had stomach pain and the usual cough that I have with allergies.
Systemic: Flushed / Sweating-Medium, Systemic: Seizure-Mild, Additional Details: I did not witness the event but girlfriend started yelling for help saying that patient was seizing and when I got to him he was alert and sweating.
Information has been received from a registered nurse concerning a female with a history of ace inhibitor cough who on an unspecified date was vaccinated with ZOSTAVAX (Oka/Merck).  The nurse reports that a physician has a patient that developed an adverse reaction following vaccination with ZOSTAVAX (Oka/Merck).  The vaccination was administered at another site and the nurse did not have information about the administration.  The adverse reaction was believed to be the development of Bells palsy.  No time frame for development was available.  At the time of the report the outcome of the patient was unknown.  There was no product quality complaint.  Bells palsy was considered to be disabling.  Additional information has been requested.